JPWO2020249667A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020249667A5
JPWO2020249667A5 JP2021573382A JP2021573382A JPWO2020249667A5 JP WO2020249667 A5 JPWO2020249667 A5 JP WO2020249667A5 JP 2021573382 A JP2021573382 A JP 2021573382A JP 2021573382 A JP2021573382 A JP 2021573382A JP WO2020249667 A5 JPWO2020249667 A5 JP WO2020249667A5
Authority
JP
Japan
Prior art keywords
alkyl
disease
disorder
cycloalkyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021573382A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022535956A5 (https=
JP7682813B2 (ja
JP2022535956A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/066191 external-priority patent/WO2020249667A1/en
Publication of JP2022535956A publication Critical patent/JP2022535956A/ja
Publication of JP2022535956A5 publication Critical patent/JP2022535956A5/ja
Publication of JPWO2020249667A5 publication Critical patent/JPWO2020249667A5/ja
Application granted granted Critical
Publication of JP7682813B2 publication Critical patent/JP7682813B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021573382A 2019-06-12 2020-06-11 スルホニル尿素誘導体及びその使用 Active JP7682813B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962860663P 2019-06-12 2019-06-12
US62/860,663 2019-06-12
PCT/EP2020/066191 WO2020249667A1 (en) 2019-06-12 2020-06-11 Sulfonylurea derivatives and uses thereof

Publications (4)

Publication Number Publication Date
JP2022535956A JP2022535956A (ja) 2022-08-10
JP2022535956A5 JP2022535956A5 (https=) 2023-06-19
JPWO2020249667A5 true JPWO2020249667A5 (https=) 2023-06-19
JP7682813B2 JP7682813B2 (ja) 2025-05-26

Family

ID=71108563

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021573382A Active JP7682813B2 (ja) 2019-06-12 2020-06-11 スルホニル尿素誘導体及びその使用

Country Status (16)

Country Link
US (1) US12054461B2 (https=)
EP (1) EP3983387B1 (https=)
JP (1) JP7682813B2 (https=)
CN (1) CN114641466B (https=)
DK (1) DK3983387T3 (https=)
ES (1) ES2983661T3 (https=)
FI (1) FI3983387T3 (https=)
HR (1) HRP20240896T1 (https=)
HU (1) HUE067378T2 (https=)
LT (1) LT3983387T (https=)
PL (1) PL3983387T3 (https=)
PT (1) PT3983387T (https=)
RS (1) RS65711B1 (https=)
SI (1) SI3983387T1 (https=)
SM (1) SMT202400291T1 (https=)
WO (1) WO2020249667A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201721185D0 (en) 2017-12-18 2018-01-31 Nodthera Ltd Sulphonyl urea derivatives
PL3983387T3 (pl) 2019-06-12 2024-08-19 NodThera Limited Pochodne sulfonylomocznika i ich zastosowania
KR102802013B1 (ko) * 2021-02-03 2025-05-07 환인제약 주식회사 알츠하이머병 치료를 위한 nlrp3 인플라마좀 소분자 억제제

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2110689A (en) 1981-12-03 1983-06-22 Sandoz Ltd Herbicidal heterocyclic aminosulfonyl ureas and isoureas
CH649081A5 (de) 1982-01-12 1985-04-30 Ciba Geigy Ag Triaza-verbindungen.
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
JPS60214785A (ja) * 1984-03-27 1985-10-28 Nissan Chem Ind Ltd ピラゾ−ルスルホニルウレア誘導体、および植物生長調節剤または除草剤
US5214206A (en) 1990-11-07 1993-05-25 Warner-Lambert Company Aminosulfonyl urea acat inhibitors
CA2115990A1 (en) 1991-08-19 1993-03-04 George Albert Boswell Angiotensin ii receptor blocking imidazolinone derivatives
WO1993004045A1 (en) 1991-08-19 1993-03-04 E.I. Du Pont De Nemours And Company Angiotensin ii receptor blocking imidazolinone derivatives
NZ247440A (en) 1992-05-06 1995-04-27 Squibb & Sons Inc Phenyl sulphonamide derivatives, preparation and pharmaceutical compositions thereof
DE4217719A1 (de) * 1992-05-29 1993-12-02 Bayer Ag Zweifach heterocyclisch substituierte Sulfonylamino(thio)carbonylverbindungen
DE4302701A1 (de) 1993-02-01 1994-08-04 Bayer Ag Arylaminosulfonylharnstoffe
DE4302702A1 (de) 1993-02-01 1994-08-04 Bayer Ag Arylaminosulfonylharnstoffe
JP3355237B2 (ja) 1993-10-15 2002-12-09 呉羽化学工業株式会社 N−(置換アミノ)ピロール誘導体、その製造方法及び除草剤
JPH0827147A (ja) * 1994-07-20 1996-01-30 Kureha Chem Ind Co Ltd N−(置換アミノ)イミド誘導体、その製造方法及び除草剤
JPH09132574A (ja) 1995-11-09 1997-05-20 Nissan Chem Ind Ltd フルオロプロピルチアゾリン誘導体の製造法
US5763263A (en) 1995-11-27 1998-06-09 Dehlinger; Peter J. Method and apparatus for producing position addressable combinatorial libraries
US6028201A (en) 1996-01-30 2000-02-22 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
AU3440597A (en) 1996-07-02 1998-01-21 Novartis Ag N-phenylimino heterocyclic derivatives and their use as herbicides
JPH1029990A (ja) 1996-07-12 1998-02-03 Kureha Chem Ind Co Ltd 1−(置換アミノ)イミダゾール誘導体、その製造方法及び除草剤
DE19651037A1 (de) 1996-12-09 1998-06-10 Bayer Ag Substituierte Thienyl(amino)sulfonyl(thio)harnstoffe
PT1270565E (pt) 1997-01-29 2004-09-30 Pfizer Furano-2-sulfonamida 4-substituida e sua utilizacao na preparacao de derivados de sulfonilureia
IT1290062B1 (it) 1997-03-13 1998-10-19 Isagro Ricerca Srl Amminosolfoniluree ad attivita' erbicida
GB9909409D0 (en) 1999-04-24 1999-06-23 Zeneca Ltd Chemical compounds
DE19937118A1 (de) 1999-08-06 2001-02-08 Bayer Ag Substituierte Thienyl(amino)sulfonylharnstoffe
JP4112127B2 (ja) 1999-08-31 2008-07-02 株式会社リコー 感熱記録材料
AU7447500A (en) 1999-09-30 2001-04-30 Mitsubishi Chemical Corporation Acylsulfonamide derivatives
US6593356B2 (en) 1999-10-20 2003-07-15 Bristol-Myers Squibb Pharma Company Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents
EP1281399A3 (en) 2001-08-01 2004-02-11 Warner-Lambert Company Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production
WO2003029226A1 (en) 2001-09-26 2003-04-10 Basf Aktiengesellschaft Heterocyclyl substituted phenoxyalkyl-, phenylthioalkyl-, phenylaminoalkyl- and phenylalkyl-sulfamoylcarboxamides
US7202257B2 (en) 2003-12-24 2007-04-10 Deciphera Pharmaceuticals, Llc Anti-inflammatory medicaments
US7279576B2 (en) 2002-12-31 2007-10-09 Deciphera Pharmaceuticals, Llc Anti-cancer medicaments
US7144911B2 (en) 2002-12-31 2006-12-05 Deciphera Pharmaceuticals Llc Anti-inflammatory medicaments
US20070191336A1 (en) 2003-12-24 2007-08-16 Flynn Daniel L Anti-inflammatory medicaments
AU2005325676A1 (en) 2004-12-23 2006-08-03 Deciphera Pharmaceuticals, Llc Anti-inflammatory medicaments
CA2709784A1 (en) 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
WO2013119040A1 (en) 2012-02-07 2013-08-15 Kainos Medicine, Inc. Compounds as inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
CN103288750A (zh) 2013-03-04 2013-09-11 盐城工学院 新型氨基磺酰脲类化合物
US9410217B2 (en) 2014-02-18 2016-08-09 Renmatix, Inc. Method of reducing a fermentation and/or enzyme inhibitor in a saccharide-containing composition
SI3259253T1 (sl) 2015-02-16 2020-07-31 The University Of Queensland Sulfonilsečnine in sorodne spojine ter njihova uporaba
JP2019512009A (ja) 2016-02-16 2019-05-09 ザ・ユニバーシティ・オブ・クイーンズランド スルホニルウレアおよび関連化合物ならびにこれらの利用
US10080741B2 (en) 2016-04-26 2018-09-25 Enanta Pharmaceuticals, Inc. Isoxazole derivatives as FXR agonists and methods of use thereof
WO2017189663A1 (en) 2016-04-26 2017-11-02 Enanta Pharmaceuticals, Inc. Isoxazole derivatives as fxr agonists and methods of use thereof
WO2017189651A1 (en) 2016-04-26 2017-11-02 Enanta Pharmaceuticals, Inc. Isoxazole derivatives as fxr agonists and methods of use thereof
WO2017201150A1 (en) 2016-05-18 2017-11-23 Enanta Pharmaceuticals, Inc. Isoxazole analogs as fxr agonists and methods of use thereof
WO2017201155A1 (en) 2016-05-18 2017-11-23 Enanta Pharmaceuticals, Inc. lSOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF
WO2017201152A1 (en) 2016-05-18 2017-11-23 Enanta Pharmaceuticals, Inc. Isoxazole derivatives as fxr agonists and methods of use thereof
EP3272739A1 (en) * 2016-07-20 2018-01-24 NodThera Limited Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
ES2988798T3 (es) 2017-07-24 2024-11-21 Novartis Ag Compuestos y composiciones para el tratamiento de afecciones asociadas a la actividad de NLRP
MA49903A (fr) 2017-08-15 2020-06-24 Inflazome Ltd Sulfonylureés et sulfonylthioureés en tant qu'inhibiteurs de nlrp3
EP3668840A1 (en) 2017-08-15 2020-06-24 Inflazome Limited Novel sulfonamide carboxamide compounds
JP2020531435A (ja) * 2017-08-15 2020-11-05 インフレイゾーム リミテッド 新規なスルホンアミドカルボキサミド化合物
UY37848A (es) 2017-08-15 2019-03-29 Inflazome Ltd Sulfonilureas y sulfoniltioureas útiles como inhibidores de nlrp3
US20210122739A1 (en) 2017-08-15 2021-04-29 Inflazome Limited Novel sulfonamide carboxamide compounds
EP3668843A1 (en) 2017-08-15 2020-06-24 Inflazome Limited Sulfonylureas and sulfonylthioureas as nlrp3 inhibitors
EP3668601A1 (en) 2017-08-15 2020-06-24 Inflazome Limited Novel sulfonamide carboxamide compounds
GB201721185D0 (en) * 2017-12-18 2018-01-31 Nodthera Ltd Sulphonyl urea derivatives
GB201902327D0 (en) * 2019-02-20 2019-04-03 Inflazome Ltd Novel compounds
KR20210053910A (ko) * 2018-08-15 2021-05-12 인플라좀 리미티드 신규한 설폰아마이드유레아 화합물
PL3983387T3 (pl) 2019-06-12 2024-08-19 NodThera Limited Pochodne sulfonylomocznika i ich zastosowania
EP3983388A1 (en) 2019-06-12 2022-04-20 Nodthera Limited Sulfonamide derivatives and uses thereof
JP7661248B2 (ja) 2019-06-12 2025-04-14 ノッドセラ リミテッド スルホニル尿素誘導体及びその使用
IL301055A (en) 2020-09-04 2023-05-01 Nodthera Ltd Sulphamoyl urea derivatives containing alkyl-oxacycloalkyl moiety and uses thereof

Similar Documents

Publication Publication Date Title
HRP20250964T1 (hr) Derivati sulfonil ureje kao modulatori nlrp3 inflamasoma
JP2020514415A5 (https=)
HRP20201263T1 (hr) Natrijeva sol od n-((1,2,3,5,6,7-heksahidro-s-indacen-4-il)karbamoil)-1-izopropil-1h-pirazol-3-sulfonamida
JP2020537657A5 (https=)
JP2017526716A5 (https=)
JP2020528889A5 (https=)
JP2021523159A5 (https=)
JP2019519598A5 (https=)
HRP20201219T1 (hr) Anti-vla-4 antitijela
CN108366979B (zh) 与泛素化-蛋白酶体系统有关的化合物及医药组合物
JP2017522352A5 (https=)
JP2020519654A5 (https=)
JP2023036007A5 (https=)
BRPI0607860A2 (pt) composição farmacêutica para o tratamento ou prevenção de doenças envolvendo obesidade, diabetes, sìndrome metabólica, doenças neuro--degenerativas e doenças de disfunção da mitocÈndria
IN2014MN01839A (https=)
JP2016519650A5 (https=)
RU2020109881A (ru) Агонисты рецепторов glp-1/глюкагона в лечении жировой болезни печени и стеатогепатита
JP2018531289A5 (https=)
WO2012116176A3 (en) Asymmetric ureas and medical uses thereof
RU2018107693A (ru) Комбинированные виды лечения и их варианты применения и способы
JP2018529661A5 (https=)
WO2023125825A1 (en) Anticoronviral compounds and compositions and uses thereof
TWI469980B (zh) 製備(+)-1,4-二氫-7-〔(3s,4s)-3-甲氧基-4-(甲胺基)-1-吡咯啶基〕-4-酮基-1-(2-噻唑基)-1,8-萘啶-3-羧酸之方法
JP2018509426A5 (https=)
HRP20240896T1 (hr) Derivati sulfoniluree i njihova upotreba